Exelixis (EXEL) Other Non-Current Assets (2010 - 2022)

Exelixis' (EXEL) quarterly Other Non-Current Assets came in at $280.0 million in Q3 2022, up 107.91% year-on-year from $134.7 million in Q3 2021, and little changed quarter-over-quarter from $279.7 million in Q3 2022.

Exelixis (EXEL) Other Non-Current Assets (2010 - 2022) Analysis & Trends

Exelixis' Other Non-Current Assets history runs 13 years deep, the most recent figure standing at $280.0 million for Q3 2022.

  • On a quarterly basis, Other Non-Current Assets rose 107.91% year-over-year to $280.0 million in Q3 2022; TTM through Sep 2022 was $280.0 million, a 107.91% increase from a year earlier, with the FY2021 full-year figure at $131.0 million, up 78.46% from the prior year.
  • Other Non-Current Assets was little changed at $280.0 million in Q3 2022 per EXEL's latest filing, from $279.7 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $280.0 million in Q3 2022 and bottomed at $1.1 million in Q2 2018.
  • The 5-year median for Other Non-Current Assets is $60.5 million (2020), against an average of $82.3 million.
  • Across the five-year window, Other Non-Current Assets retreated 26.67% in 2019 and surged 5110.18% in 2020, its largest moves.
  • Year by year, Other Non-Current Assets stood at $8.3 million in 2018, then retreated by 12.34% to $7.3 million in 2019, then jumped by 854.99% to $69.4 million in 2020, then surged by 88.74% to $131.0 million in 2021, then jumped by 113.74% to $280.0 million in 2022.
  • Per Business Quant, the three latest EXEL Other Non-Current Assets figures stand at $280.0 million (Q3 2022), $279.7 million (Q3 2022), and $139.0 million (Q2 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2022 280.01 Mn
Jul 1, 2022 279.71 Mn
Apr 1, 2022 138.99 Mn
Dec 31, 2021 131.00 Mn
Oct 1, 2021 134.68 Mn
Jul 2, 2021 134.93 Mn
Apr 2, 2021 124.68 Mn
Jan 1, 2021 73.41 Mn
Oct 2, 2020 69.41 Mn
Jul 3, 2020 60.50 Mn
Apr 3, 2020 57.31 Mn
Jan 3, 2020 53.15 Mn
Sep 27, 2019 7.27 Mn
Jun 28, 2019 5.76 Mn
Mar 29, 2019 1.10 Mn
Dec 28, 2018 8.29 Mn
Sep 28, 2018 1.10 Mn
Jun 29, 2018 1.10 Mn
Mar 30, 2018 1.50 Mn
Dec 29, 2017 4.65 Mn